International migration has become a major global issue generating huge economic, social, and cultural consequences in both countries of origin and countries of destination. Europe has become an ...
For patients with HIV, many factors may influence medication adherence throughout multiple points of their disease course.
Gilead Sciences, Inc. (Nasdaq: GILD) today announced the upcoming presentation of HIV research findings at the International ...
As SADC Health Ministers meet in Harare to discuss various issues affecting the region, there have been calls for the harmonisation of the region's HIV treatment regimens to improve access to ...
Many patients with HIV have untreated anxiety symptoms, and findings show that viral suppression is worst in patients with untreated moderate-to-severe anxiety.
Uganda has made major strides in reducing the number of infants born with HIV, but persistent challenges remain in achieving ...
A new WHO report sheds light on the latest advancements in optimizing second- and third-line HIV treatment. The comprehensive ...
A clinical trial sponsored by the National Institutes of Health (NIH) has launched to examine the safety and acceptability of ...
Researchers assessed the safety and efficacy of first-line antiretroviral therapy with bictegravir plus emtricitabine and tenofovir alafenamide in Black patients with HIV.
People living with HIV (PWH) can have mental health implications related to their neighborhood markers and environment.